Q&A

Time: 11:00 am
day: Agenda: Risks, Dead-ends & Avoidable Delays: Optimising Preclinical Planning & Biomarker Targets to Maximise Clinical Development in Precision & Immuno-Oncology

Details:

You can take part in this interactive Q&A by submitting questions via the live chat tab

Speakers: